This legislation aims to prevent consumer confusion by establishing clear definitions for "egg" and "egg product" in food labeling. It amends the Federal Food, Drug, and Cosmetic Act to specify that an egg must be the reproductive output of avian poultry, including an albumen or yolk encased in a calcium-based shell, and an egg product must adhere to existing federal regulations. The bill prohibits any food from being introduced into interstate commerce using a market name for an egg or egg product if it does not meet these newly defined criteria. This measure is intended to ensure that plant-based or other alternatives are not mislabeled in a way that could mislead consumers about their nutritional content or origin, as eggs are recognized for their unique nutritional profile. To facilitate enforcement, the Secretary of Health and Human Services, through the Commissioner of Food and Drugs, must issue draft guidance within 180 days and final guidance within one year. Any existing guidance inconsistent with these new definitions will be rendered void. The legislation also mandates a report to Congress within two years detailing enforcement actions, including warnings and penalties, and an updated plan if misbranded products remain on the market.
This legislation aims to prevent consumer confusion by establishing clear definitions for "egg" and "egg product" in food labeling. It amends the Federal Food, Drug, and Cosmetic Act to specify that an egg must be the reproductive output of avian poultry, including an albumen or yolk encased in a calcium-based shell, and an egg product must adhere to existing federal regulations. The bill prohibits any food from being introduced into interstate commerce using a market name for an egg or egg product if it does not meet these newly defined criteria. This measure is intended to ensure that plant-based or other alternatives are not mislabeled in a way that could mislead consumers about their nutritional content or origin, as eggs are recognized for their unique nutritional profile. To facilitate enforcement, the Secretary of Health and Human Services, through the Commissioner of Food and Drugs, must issue draft guidance within 180 days and final guidance within one year. Any existing guidance inconsistent with these new definitions will be rendered void. The legislation also mandates a report to Congress within two years detailing enforcement actions, including warnings and penalties, and an updated plan if misbranded products remain on the market.